First In Class, Orally Active Toll-Like Receptor Signaling Inhibitor Mosedipimod (Plag) Attenuates Molecular, Biochemical And Histological Features Of Non-Alcoholic Steatohepatitis (Nash) In Vitro And In Vivo
JOURNAL OF HEPATOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要